3/13
08:19 pm
cccc
C4 Therapeutics Details MOMENTUM Phase 2 Start, Eyes Near-Term Decision on EGFR Program at Barclays Confab [Yahoo! Finance]
Low
Report
C4 Therapeutics Details MOMENTUM Phase 2 Start, Eyes Near-Term Decision on EGFR Program at Barclays Confab [Yahoo! Finance]
3/10
10:57 am
cccc
C4 Therapeutics, Inc. (CCCC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Medium
Report
C4 Therapeutics, Inc. (CCCC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/10
07:50 am
cccc
C4 Therapeutics: Cemsidomide Progress Keeps The Long-Term Thesis Intact [Seeking Alpha]
Medium
Report
C4 Therapeutics: Cemsidomide Progress Keeps The Long-Term Thesis Intact [Seeking Alpha]
3/9
08:36 pm
cccc
C4 Therapeutics (CCCC) Well Positioned With Cemsidomide Trial Data [Yahoo! Finance]
High
Report
C4 Therapeutics (CCCC) Well Positioned With Cemsidomide Trial Data [Yahoo! Finance]
3/9
04:01 pm
cccc
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
High
Report
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
3/7
12:36 pm
cccc
C4 Therapeutics Maps Accelerated Approval Path for Myeloma Drug Cemsidomide at TD Cowen Conference [Yahoo! Finance]
High
Report
C4 Therapeutics Maps Accelerated Approval Path for Myeloma Drug Cemsidomide at TD Cowen Conference [Yahoo! Finance]
3/5
09:00 am
cccc
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
Low
Report
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
2/28
01:30 am
cccc
High
Report
2/26/2026
07:00 am
cccc
c4 therapeutics, inc.
BEAT
Report
-3.5%
c4 therapeutics, inc.
11/6/2025
07:00 am
cccc
c4 therapeutics, inc.
BEAT
Report
-0.8%
c4 therapeutics, inc.
8/7/2025
07:00 am
cccc
c4 therapeutics, inc.
BEAT
Report
31.6%
c4 therapeutics, inc.
3/9
04:20 pm
cccc
Form 144 C4 Therapeutics, Inc. Filed by: Siegel Jolie
High
Report
Form 144 C4 Therapeutics, Inc. Filed by: Siegel Jolie
2/26
07:52 am
cccc
Form S-8 C4 Therapeutics, Inc.
Medium
Report
Form S-8 C4 Therapeutics, Inc.
2/26
07:50 am
cccc
Form 10-K C4 Therapeutics, Inc. For: Dec 31
Medium
Report
Form 10-K C4 Therapeutics, Inc. For: Dec 31
2/26
07:10 am
cccc
Form 8-K C4 Therapeutics, Inc. For: Feb 26
Medium
Report
Form 8-K C4 Therapeutics, Inc. For: Feb 26
2/18
05:05 pm
cccc
Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Boyle Scott N
Medium
Report
Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Boyle Scott N
2/18
05:05 pm
cccc
Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Hirsch Andrew
Medium
Report
Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Hirsch Andrew
2/18
05:05 pm
cccc
Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Mahaney Paige
Medium
Report
Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Mahaney Paige
2/18
05:05 pm
cccc
Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Mossler Mark
Medium
Report
Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Mossler Mark
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register